Noradrenergic neurons of the locus coeruleus: inhibition by epinephrine and activation by the α-antagonist piperoxane
References (40)
- et al.
Evidence for a central noradrenaline receptor stimulation by clonidine
Life Sci.
(1970) - et al.
Possible involvement of central adrenaline neurons in vasomotor and respiratory control. Studies with clonidine and its interactions with piperoxane and yohimbine
Europ. J. Pharmacol.
(1974) - et al.
Sedative effects of α-sympathomimetic drugs and their antagonism by adrenergic and cholinergic blocking drugs
Europ. J. Pharmacol.
(1971) - et al.
Studies on norepinephrine containing afferents to Purkinje cells of rat cerebellum. II. Sensitivity of Purkinje cells to norepinephrine and related substances administered by microiontophoresis
Brain Research
(1971) - et al.
Immunohistochemical evidence for the existence of adrenaline neurons in the rat brain
Brain Research
(1974) - et al.
The effect of lesions of catecholamines-containing neurons upon monoamine content of the brain and EEG and behavioral waking in the cat
Brain Research
(1973) - et al.
Effects of clonidine and BS 100–141 on the EEG sleep pattern in rats
Europ. J. Pharmacol.
(1975) - et al.
Noradrenergic neurons: morphine inhibition of spontaneous activity
Europ. J. Pharmacol.
(1974) The effects of lesions of ascending noradrenaline pathways on sleep and waking in the rat
Brain Research
(1974)- et al.
Tricyclic antidepressants: effects on the firing rate of brain noradrenergic neurons
Europ. J. Pharmacol.
(1975)
Interactions between 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (St 155, catapresan®) and α-adrenergic blocking drugs
Europ. J. Pharmacol.
Evidence for an α-sympathomimetic component in the effects of catapresan on vasomotor centres: antagonism by piperoxane
Europ. J. Pharmacol.
The action of norepinephrine in the rat hippocampus. I. Iontophoretic studies
Brain Research
The action of norepinephrine in the rat hippocampus. II. Activation of the input pathway
Brain Research
Inhibition of adrenergic neurotransmission by clonidine: an action on prejunctional α-receptors
Neuropharmacology
Involvement of α-receptors in clonidine-induced inhibition of transmitter release from central monoamine neurons
Neuropharmacology
Inhibition of both noradrenergic and serotonergic neurons in brain by the α-adrenergic agonist clonidine
Brain Research
Adrenergic receptor blocking agents: effects on central noradrenaline receptors and on motor activity
Psychopharmacologia (Berl.)
Epinephrine formation and metabolism in mammalian brain
Biol. Psychiat.
D and L amphetamine stereoisomers: comparative potencies in affecting the firing of central dopaminergic and noradrenergic neurons
Psychopharmacol. Commun.
Cited by (459)
Bidirectional pharmacological perturbations of the noradrenergic system differentially affect tactile detection
2020, NeuropharmacologyCitation Excerpt :Agonizing α2 ARs suppresses LC-NE signaling by hyperpolarizing LC neurons and reducing NE release in downstream areas (Abercrombie and Jacobs, 1987; Adams and Foote, 1988; Aghajanian and VanderMaelen, 1982; Aghajanian and Wang, 1987; Berridge et al., 1993; Cedarbaum and Aghajanian, 1977; Kalwani et al., 2014). Conversely, antagonists acting on α2 ARs increase LC neuron excitability and spiking response to stimuli as well as NE release (Adams and Foote, 1988; Aghajanian and VanderMaelen, 1982; Cedarbaum and Aghajanian, 1976; Herr et al., 2012; Raiteri et al., 1983; Rasmussen and Jacobs, 1986; Simson and Weiss, 1987). Human studies have reported that systemically up- or down-regulating NE signaling (mainly through targeting α2 ARs) affected subjects performing perception-related tasks (Gelbard-Sagiv et al., 2018; Halliday et al., 1989; Turetsky and Fein, 2002).
Chronic fluoxetine reverses the effects of chronic corticosterone treatment on α<inf>2</inf>-adrenoceptors in the rat frontal cortex but not locus coeruleus
2019, NeuropharmacologyCitation Excerpt :The exact location of these α2A-adrenoceptors is controversial, and therefore, clear information about the origin and regulation of the somatodendritic NA in the LC is still unavailable. A second subpopulation, corresponding also to the α2A-adrenoceptor subtype, exerts a tonic inhibition on firing activity of LC neurons (Cedarbaum and Aghajanian, 1976; Fernandez-Pastor and Meana, 2002; Mateo and Meana, 1999; Van et al., 1997). This inhibition of LC neuron activity induces a decrease in the action potential-dependent NA release in noradrenergic projection areas such as the PFC (Fernandez-Pastor and Meana, 2002; Mateo and Meana, 1999; Van et al., 1997).
Comorbid anxiety-like behavior and locus coeruleus impairment in diabetic peripheral neuropathy: A comparative study with the chronic constriction injury model
2016, Progress in Neuro-Psychopharmacology and Biological PsychiatryCitation Excerpt :Rats were anesthetized with chloral hydrate (400 mg/kg i.p. followed by 60–70 mg/kg/h via perfusion pump) and placed in a stereotaxic frame. The recording electrode was lowered into the LC (anterior-posterior − 3.7 mm, latero-medial − 1.1 mm, dorso-ventral − 7.0 mm relative to lambda) (Paxinos and Watson, 2009) and neurons were identified using the following well-established criteria (Cedarbaum and Aghajanian, 1976): long-duration action potential (> 2 ms), spontaneous firing at a regular rhythm, a slow firing rate between 0.5 and 5.0 Hz, and characteristic spikes with a long-lasting positive-negative waveform. Firing patterns were analyzed offline using Spike2 computer software (Cambridge Electronic Design, UK).
This research was supported by NIMH Grants MH-17871 and MH-14459, the State of Connecticut, and Yale University (Medical Student Summer Research Fellowship to J.M. Cedarbaum).